Myriad Genetics, Inc.MYGNNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank36
Studio
Year-over-Year Change

Free cash flow yield

Latest
0.31%
↑ 130% vs avg
Percentile
P36
Within normal range
Streak
3 yr
Consecutive growthElevated
Average
-1.05%
Historical baseline
PeriodValueYoY Change
20250.31%+110.1%
2024-3.09%+73.4%
2023-11.62%+10.4%
2022-12.97%-46454.0%
20210.03%+101.0%
2020-2.72%-145.3%
20195.99%+61.3%
20183.72%-10.3%
20174.15%-26.9%
20165.67%-